EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
   2.4.1.149 | Walker-Warburg Syndrome |
23877401 |
A truncating mutation in B3GNT1 causes severe Walker-Warburg syndrome. |
causal interaction
unassigned |
4
0 |
| 2.4.1.149 | Endometrial Neoplasms |
33683574 |
B3GNT3 acts as a carcinogenic factor in endometrial cancer via facilitating cell growth, invasion and migration through regulating RhoA/RAC1 pathway-associated markers. |
causal interaction
unassigned |
3
0 |
| 2.4.1.149 | Neoplasms |
33683574 |
B3GNT3 acts as a carcinogenic factor in endometrial cancer via facilitating cell growth, invasion and migration through regulating RhoA/RAC1 pathway-associated markers. |
causal interaction
unassigned |
3
0 |
| 2.4.1.149 | Infections |
26709519 |
B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
4
4 |
| 2.4.1.149 | Lymphatic Metastasis |
26709519 |
B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
4
4 |
| 2.4.1.149 | Neoplasm Metastasis |
26709519 |
B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
4
4 |
| 2.4.1.149 | Neoplasms |
26709519 |
B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
4
4 |
| 2.4.1.149 | Uterine Cervical Neoplasms |
26709519 |
B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
4
4 |
| 2.4.1.149 | Neoplasms |
24118321 |
B3GNT3 expression suppresses cell migration and invasion and predicts favorable outcomes in neuroblastoma. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
2
4
1
0 |
| 2.4.1.149 | Neuroblastoma |
24118321 |
B3GNT3 expression suppresses cell migration and invasion and predicts favorable outcomes in neuroblastoma. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
2
4
1
0 |
